Meet our team
Discover our partners
FAQ
-
We have successfully developed the technical concept and are in the process of validating our PoC under controlled laboratory conditions in collaboration with the Engineering for Health Interdisciplinary Centre (E4H). Looking ahead, we plan to conduct field trials of our technology in 2025. By 2026, we anticipate launching our first product, a collective alert system, in the EU market.
If you are interested in participating in the field testing of our prototype or wish to collaborate on our R&D activities, please do not hesitate to contact us.
Yes. Our technology involves the use of nanobodies that are specifically designed to target the corresponding antigens of different virus species, with each detection module dedicated to one virus type. While our current technology does not allow the identification of unknown viral species in the air, we can adapt our biomanufacturing process to detect new viruses as their genome sequences are determined. This adaptability allows us to respond quickly to emerging viral threats.
Yes. The modularity of our devices enables a wide range of configurations, allowing for seamless integration into existing ventilation, air conditioning, and air quality monitoring systems. This flexibility ensures that VAir devices can be adapted to enhance the functionality of current systems by adding advanced viral detection capabilities.
If you are interested in exploring how our solutions can augment your existing products, please do not hesitate to contact us for more information.
In addition to push notifications sent through our mobile application, we provide a diverse range of notification options to meet various communication needs. Our system supports text messages, emails, and web hooks, ensuring that you receive timely updates in your preferred format. If you have specific needs or would like to suggest a customized integration with a software of your choice, please do not hesitate to contact us!
VAir offers two payment models to accommodate different customer preferences. The first option is a subscription model, which provides ongoing access to a biosensor of the chosen configuration, a mobile application, exposure notifications, and replaceable detection modules that are delivered upon request every 3-4 months. This subscription automatically renews until the customer decides to terminate the service. Alternatively, customers can opt for a one-time purchase of the device, with the option to buy additional detection modules as needed.
As our products are currently in the R&D stage, we cannot provide exact pricing at this time. However, our goal is to offer better value for money compared to existing aerosol bio-analyzers, which typically start at prices around $20,000 and often lack specificity for different virus species.
We are also conducting a market study to refine our offerings based on the needs and preferences of potential clients. If you are interested in the VAir products and considering using them in your workplace or home, please contact us. We value your input and engagement as we continue to develop our technology.